Dopamine release modifies intracellular calcium levels in tyrosine hydroxylase-transfected C6 cells

Brain Research Bulletin

Volumn 74, Issue 1-3, 2007, Pages 113-118

  Guerrero Cázares, Hugo ^a   Alatorre Carranza, María del Pilar ^a   Delgado Rizo, Vidal ^a   Duenas Jimenez, Judith Marcela ^a   Mendoza Magana, Maria Luisa ^a   Morales Villagran, Alberto ^a   Ramirez Herrera, Mario A ^a   Guerrero Hernández, Agustin ^b   Segovia, Jose ^b   Duenas Jimenez, Sergio H ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Dopamine receptors; Fluo 3; Glial cells; L 745,870; Neurotransmitter release; SCH 23390

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BETA ACTIN; CALCIUM ION; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; POTASSIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG EFFECT; DRUG INHIBITION; FEEDBACK SYSTEM; GLIA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOPAMINE ANTAGONISTS; GLIOMA; GLUTAMIC ACID; INTRACELLULAR SPACE; MICE; POTASSIUM CHLORIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TRANSFECTION; TYROSINE 3-MONOOXYGENASE;

EID: 34547549162     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2007.05.008     Document Type: Article

References (35)

1. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
2. Brenner M., Kisseberth W.C., Su Y., Besnard F., and Messing A. GFAP promoter directs astrocyte-specific expression in transgenic mice. J. Neurosci. 14 (1994) 1030-1037
3. Cao L., Zhao Y.C., Jiang Z.H., Xu D.H., Liu Z.G., Chen S.D., Liu X.Y., and Zheng Z.C. Long-term phenotypic correction of rodent hemiparkinsonism by gene therapy using genetically modified myoblasts. Gene Ther. 7 (2000) 445-449
4. Cortez N., Trejo F., Vergara P., and Segovia J. Primary astrocytes retrovirally transduced with a tyrosine hydroxylase transgene driven by a glial-specific promoter elicit behavioral recovery in experimental parkinsonism. J. Neurosci. Res. 59 (2000) 39-46
5. Fisher L.J., Jinnah H.A., Kale L.C., Higgins G.A., and Gage F.H. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-Dopa. Neuron 6 (1991) 371-380
6. Gasman S., Chasserot-Golaz S., Bader M.F., and Vitale N. Regulation of exocytosis in adrenal chromaffin cells: focus on ARF and Rho GTPases. Cell Signal. 15 (2003) 893-899
7. Hida H., Hashimoto M., Fujimoto I., Nakajima K., Shimano Y., Nagatsu T., Mikoshiba K., and Nishino H. Dopa-producing astrocytes generated by adenoviral transduction of human tyrosine hydroxylase gene: in vitro study and transplantation to hemiparkinsonian model rats. Neurosci. Res. 35 (1999) 101-112
8. Horellou P., Guibert B., Leviel V., and Mallet J. Retroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: regulated release of dopamine in mouse anterior pituitary AtT-20 cells. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 7233-7237
9. Imoto K., Takemura H., Kaneko M., and Ohshika H. Lack of voltage-operated calcium channel in rat glioma C6 cells. Res. Commun. Mol. Pathol. Pharmacol. 93 (1996) 249-256
10. Juorio A.V., Li X.M., Walz W., and Paterson I.A. Decarboxylation of l-Dopa by cultured mouse astrocytes. Brain Res. 626 (1993) 306-309
11. Lampela P., Huotari M., Harjula A., Oinonen L., Ustav M., Yla-Herttuala S., Mannisto P.T., and Raasmaja A. Production of functional recombinant tyrosine hydroxylase by the BPV-1 expression plasmids in the cell cultures. Plasmid 50 (2003) 230-235
12. Li X.M., Juorio A.V., Paterson I.A., Walz W., Zhu M.Y., and Boulton A.A. Gene expression of aromatic l-amino acid decarboxylase in cultured rat glial cells. J. Neurochem. 59 (1992) 1172-1175
13. Lundberg C., Horellou P., Mallet J., and Bjorklund A. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model. Exp. Neurol. 139 (1996) 39-53
14. Miyazaki I., Asanuma M., Diaz-Corrales F.J., Miyoshi K., and Ogawa N. Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia. Brain Res. 1029 (2004) 120-123
15. Nagatsu T., Levitt M., and Udenfriend S. Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J. Biol. Chem. 239 (1964) 2910-2917
16. Neve K.A., Seamans J.K., and Trantham-Davidson H. Dopamine receptor signaling. J. Recept. Signal Transduct. Res. 24 (2004) 165-205
17. O'Connor E.R., and Kimelberg H.K. Role of calcium in astrocyte volume regulation and in the release of ions and amino acids. J. Neurosci. 13 (1993) 2638-2650
18. Parpura V., Liu F., Jeftinija K.V., Haydon P.G., and Jeftinija S.D. Neuroligand-evoked calcium-dependent release of excitatory amino acids from Schwann cells. J. Neurosci. 15 (1995) 5831-5839
19. Peinnequin A., Mouret C., Birot O., Alonso A., Mathieu J., Clarencon D., Agay D., Chancerelle Y., and Multon E. Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol. 5 (2004) 3
20. 2+ waves and spreading depression in the mouse neocortex. J. Neurosci. 23 (2003) 9888-9896
21. Philibert R.A., Rogers K.L., Allen A.J., Dutton G.R., and Dose-dependent. K+-stimulated efflux of endogenous taurine from primary astrocyte cultures is Ca2+-dependent. J. Neurochem. 51 (1988) 122-126
22. Segovia J., Lawless G.M., Tillakaratne N.J., Brenner M., and Tobin A.J. Cyclic AMP decreases the expression of a neuronal marker (GAD67) and increases the expression of an astroglial marker (GFAP) in C6 cells. J. Neurochem. 63 (1994) 1218-1225
23. Segovia J., Vergara P., and Brenner M. Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism. Gene Ther. 5 (1998) 1650-1655
24. Segovia J., Vergara P., and Brenner M. Differentiation-dependent expression of transgenes in engineered astrocyte cell lines. Neurosci. Lett. 242 (1998) 172-176
25. Shao Y., and McCarthy K.D. Responses of Bergmann glia and granule neurons in situ to N-methyl-d-aspartate, norepinephrine, and high potassium. J. Neurochem. 68 (1997) 2405-2411
26. Tornatore C., Baker-Cairns B., Yadid G., Hamilton R., Meyers K., Atwood W., Cummins A., Tanner V., and Major E. Expression of tyrosine hydroxylase in an immortalized human fetal astrocyte cell line; in vitro characterization and engraftment into the rodent striatum. Cell Transplant 5 (1996) 145-163
27. Trejo F., Vergara P., Brenner M., and Segovia J. Gene therapy in a rodent model of Parkinson's disease using differentiated C6 cells expressing a GFAP-tyrosine hydroxylase transgene. Life Sci. 65 (1999) 483-491
28. Uchida K., Tsuzaki N., Nagatsu T., and Kohsaka S. Tetrahydrobiopterin-dependent functional recovery in 6-hydroxydopamine-treated rats by intracerebral grafting of fibroblasts transfected with tyrosine hydroxylase cDNA. Dev. Neurosci. 14 (1992) 173-180
29. van den Pol A.N., Finkbeiner S.M., and Cornell-Bell A.H. Calcium excitability and oscillations in suprachiasmatic nucleus neurons and glia in vitro. J. Neurosci. 12 (1992) 2648-2664
30. Vitale N., Gasman S., Caumont A.S., Gensse M., Galas M.C., Chasserot-Golaz S., and Bader M.F. Insight in the exocytotic process in chromaffin cells: regulation by trimeric and monomeric G proteins. Biochimie 82 (2000) 365-373
31. Volterra A., and Bezzi P. Release of transmitters from glial cells. In: Haydon P. (Ed). The Tripartite Synapse (2002), Oxford University Press, New York 164-182
32. Vrana S.L., Kluttz B.W., and Vrana K.E. Application of quantitative RT-PCR to the analysis of dopamine receptor mRNA levels in rat striatum. Brain Res. Mol. Brain Res. 34 (1995) 127-134
33. Wang Z.H., Ji Y., Shan W., Zeng B., Raksadawan N., Pastores G.M., Wisniewski T., and Kolodny E.H. Therapeutic effects of astrocytes expressing both tyrosine hydroxylase and brain-derived neurotrophic factor on a rat model of Parkinson's disease. Neuroscience 113 (2002) 629-640
34. Wolff J.A., Fisher L.J., Xu L., Jinnah H.A., Langlais P.J., Iuvone P.M., O'Malley K.L., Rosenberg M.B., Shimohama S., Friedmann T., et al. Grafting fibroblasts genetically modified to produce l-Dopa in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 9011-9014
35. Zhuo M., Xu D.H., Cao L., Xu L.F., Yu F.R., Zheng Z.C., and Liu X.Y. Long term gene therapy of Parkinson's disease using immortalized rat glial cell line with tyrosine hydroxylase gene. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 35 (2003) 1066-1071